Medical Review: This article follows E-E-A-T principles and incorporates evidence-based research from the National Institute on Drug Abuse, SAMHSA, and peer-reviewed medical studies on methamphetamine withdrawal and treatment.

Understanding Methamphetamine Withdrawal: A Critical Phase in Recovery

Methamphetamine withdrawal represents one of the most challenging phases of addiction recovery. Unlike some substances where withdrawal symptoms are primarily physical, meth withdrawal creates a complex combination of severe psychological symptoms, intense cravings, and potential long-term...

Medical Review: This article follows E-E-A-T principles and incorporates evidence-based research from leading medical institutions including the National Institutes of Health, Cleveland Clinic, and peer-reviewed scientific studies.

The Critical Question: Which Substance Creates the Most Powerful Addiction?

When examining substance use disorders, one question frequently emerges: Is cocaine truly the hardest drug to quit? The answer, according to extensive research and clinical experience, is more complex than a simple yes or no. While cocaine presents significant challenges in addiction...

A Pioneer in Neurology and Neuro-Ophthalmology the ISSUP community honors the life and legacy of Dr. Paul N. Hoffman, Professor Emeritus of Neurology and Ophthalmology at Johns Hopkins Medicine, who passed away on October 24, 2025, at the age of 78. For over forty years, Dr. Hoffman was a leading voice in neuroscience — known globally for his pioneering research on axonal transport and neurofilament biology. His work transformed the world’s understanding of how nerve cells grow, function, and fail under disease, injury, or toxic exposure. His research profoundly influenced how we approach neurological disorders linked to substance use, including neurotoxicity, peripheral neuropathy, and neurodegeneration. By uncovering how neurons’ internal architecture determines their strength and communication, Dr. Hoffman provided essential insight into the mechanisms by which substance misuse and chemical injury disrupt neural health.

This resource outlines the health risks associated with kratom use, including short- and long-term side effects such as liver toxicity, seizures, and addiction. It is tailored for individuals in New York and Long Island, highlighting local support services like LICADD and Long Island Addiction Treatment Resources, and includes guidance on NYSHIP-covered treatment options.

Summary: Looking for drug or alcohol rehab in New York that accepts NYSHIP insurance? This guide explains how NYSHIP (The Empire Plan) covers substance use treatment, and lists trusted resources and facilities where you can use your benefits for detox, rehab, IOP, and aftercare support.

Evidence-informed guide to planning a respectful, effective drug intervention in New York. Covers when an intervention helps, the step-by-step process (assessment → plan → preparation → facilitation → handoff), ethical and safety principles, NYC borough and Long Island context, and .gov/.edu resources. Includes FAQs for families seeking a professional interventionist in NYC and statewide.

A clear, evidence-informed guide to New York interventions: when they help, how to plan them safely, and how to hand off to treatment. Includes NYC borough context, FAQs, and links to authoritative .gov/.edu resources.

Practical guidance for NYSHIP Empire Plan members on covering detox, inpatient/residential rehab, PHP/IOP, MAT, and co-occurring care at OASAS-certified programs in New York. Includes steps to verify benefits, preauthorization basics, in- vs out-of-network costs, and what to do if you’re denied.

Understand alcohol detox timelines and the differences between residential, PHP, and IOP on Long Island. Includes insurance basics (Medicaid/Medicare), family/intervention guidance, and a keyword-first Google CID map link. Internal links point to Alcohol Treatment, Residential, PHP, IOP, Interventions, and Our Location.

A professional overview of addiction treatment access, recovery policy, and intervention efforts across New York State — including Long Island and New York City — highlighting gaps in care and emerging community-based solutions.